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Abstract
Although no guidelines support the use of benzodiazepines in bereavement care, clinicians continue to use this
medication for surviving family members. An anonymous survey about perinatal death was sent to 1500 United
States obstetricians. One question assessed beliefs about prescribing sedatives to bereaved mothers. Almost half
(49%) of 804 obstetricians endorsed the use of sedatives, such as benzodiazepines, for acute bereavement. Griev-
ing families may experience mental and physical anguish after a death; however, benzodiazepines are not part
of recommended care for bereavement. The surprisingly high support from physicians for the use of sedatives
in the case of maternal grief raises important questions about how physicians can best support bereaved moth-
ers and what effect benzodiazepines may have in the grieving process.
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Introduction
ANECDOTAL REPORTS SUGGEST physicians sometimes pre-scribe benzodiazepines as treatment for acutely be-
reaved patients.1–3 We report on a large national survey of
obstetricians; the broader study measured physician experi-
ences with perinatal death, adequacy of their training in this
area, and coping patterns. The survey also assessed provider
attitudes about prescribing benzodiazepines after perinatal
death, generally defined as fetal death in the second half of
pregnancy or in the first 28 days after birth.
Materials and Methods
We conducted an anonymous mail survey of 1500 United
States obstetricians from June through September 2007.
Names were randomly selected from the American Medical
Association (AMA) Masterfile and limited to physicians
holding an active medical license. We replaced physicians if
mailings were returned undeliverable. Respondents were
sent up to three copies of the survey and a stamped return
envelope, one reminder postcard, and a $2 cash incentive
with the initial mailing. The study was approved by the in-
stitutional review board at the University of Michigan.
The survey included 51 questions about physician beliefs
and experiences regarding coping with the death of a still-
born infant or infant death. One question stated: “After a
stillbirth, I believe it can be helpful to offer sedatives (such
as benzodiazepines) to a grieving mother to help her cope
with her loss.” Results from this single question are pre-
sented in this brief communication to allow fuller discussion
of an important issue in bereavement care.
Results
Of 1500 physicians, 19 envelopes were undeliverable and
names were replaced; 15 envelopes came back undeliverable
after the close of the survey period and were not replaced.
Of 1485 completed mailings, 33 physicians returned a form
declining to participate, 2 returned incomplete surveys, and
804 completed the survey, for a usable response rate of 54%.
Respondents were 51% female; 74.5% self-identified as
white/Caucasian, 11.3% as Asian/Pacific Islander, 6.6% as
black/African American, and 7.6% as other race/ethnicity or
unknown. Median age was 46, with an average of 14 years
experience after residency; 86% were attending physicians,
and 14% were residents or fellows.
For the question about whether sedatives can be helpful
to a grieving mother, 8% marked strongly disagree, 42% dis-
agree, 42% agree, and 6.5% strongly agree (1.5% missing).
Thirteen physicians left the question blank. Female physi-
cians were less likely to endorse the use of sedatives (OR
0.53, CI 0.40-0.71, p  0.001). Female gender remained sig-
nificant (OR 0.65, CI 0.47-0.90, p  0.009) even after control-
ling for age, race, position (resident, fellow, attending), and
whether the physician reported adequate preparation to help
patients with grief and bereavement issues after perinatal
death. Older physician age also predicted support for seda-
tives in both bivariable and multivariable models. Age and
years experience were collinear, so substitution did not
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change the results. Belief that sedatives could be helpful was
not related to race, position (attending vs. trainee), being a
parent, personal/family experience with perinatal loss, a be-
lief that one’s training was inadequate, greater death anx-
iety, or personal use of substances, including prescription
medications, to cope after a death.
Discussion
Half of the obstetricians in our survey indicated prescrib-
ing sedative medications, such as benzodiazepines, could be
useful to grieving parents after the death of a baby. A few
small studies have noted similar findings. Cook et al.1 re-
cently expressed concern that 18 of 33 physicians in their
study (of primary care or geriatric physicians) spontaneously
reported prescribing benzodiazepines for bereavement. Of
112 family medicine physicians in a separate study, 55% re-
ported they would prescribe psychotropic medications to
newly bereaved parents for a short period.2 Fifteen of 37 par-
ents in a 1994 survey reported they were prescribed benzo-
diazepines after a stillbirth or infant death.3
Although some patients are unaffected by short-term use
of benzodiazepines, a subset—perhaps as many as
10%–15%—will continue using these medications on a long-
term basis.4 Psychiatric comorbidity, less education, loneli-
ness, older age, use of a benzodiazepine with a short half-
life, and repeat prescriptions all appear to be associated with
long-term use, although there is limited research in this
area.4,5 Studies show mixed results on whether initial dos-
age affects risk of long-term use.4 Benzodiazepines are com-
monly used for difficulty sleeping; however, there are alter-
native treatments for insomnia, and a large meta-analysis has
shown significant potential for side effects, including day-
time sedation, dizziness, and lightheadedness.6
The only randomized, controlled trial to date, a small
study to evaluate the use of benzodiazepines after bereave-
ment, demonstrated no benefit for grief or sleep.7 Although
a different dose could theoretically lead to a different out-
come, even at low doses, the study results suggested that in-
dividuals treated with benzodiazepines had more difficulty
resolving sleep problems in the 2 months after bereavement.
In a survey of bereaved adults, half of respondents agreed
or strongly agreed that medication could help with sleep after
bereavement, but two thirds thought it would also delay com-
ing to terms with the loss.7 Indeed, the British National For-
mulary recommends against the use of benzodiazepines for
bereavement because of concern that these medications could
inhibit normal grieving.7 Although there are likely differences
in benzodiazepine use internationally, a survey of psychiatric
experts from 44 countries found that 48% agreed benzodi-
azepines were indicated as basic treatment for anxiety follow-
ing bereavement, suggesting these views may be widespread.8
Like all cross-sectional surveys, ours was limited by po-
tential nonresponse bias. Nonresponders were not surveyed,
but respondent age and race were similar to national demo-
graphic data for obstetricians.9,10 We had a low response rate
for a national survey, although it was higher than the typi-
cal 52% rate of large, national physician surveys.11 Finally,
the survey measured opinion and may not reflect actual
practice, response to patient requests, beliefs about ideal
length of drug use, or perception of low patient risk for drug
side effects and dependence. These questions should be
evaluated in future studies of bereavement care.
This large, nationally representative study found surpris-
ingly widespread obstetrician support for sedative use in
cases of acute bereavement. Although grieving families may
experience both mental and physical anguish after a death,
benzodiazepines are not part of recommended care for fam-
ilies. The addictive nature of these medications poses a risk
to some patients and could potentially interfere with coping
and subsequent decision making. Given the lack of evidence
supporting use in bereavement and the significant potential
for adverse effects, we respectfully encourage providers to
be aware of this practice and consider other interventions to
support grieving patients and families.
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